Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

A.H. van Lierop, A.W. van der Eerden, N.A.T. Hamdy, A.R. Hermus, M. den Heijer, S.E. Papapoulos

Research output: Contribution to journalArticleAcademicpeer-review

73 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)E1953-E1957
JournalJournal of Clinical Endocrinology and Metabolism
Issue number10
Publication statusPublished - 2012

Cite this